{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69423-987",
      "marketing_end_date": "20270506",
      "generic_name": "Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION",
      "brand_name_suffix": "COLD and FLU plus CONGESTION",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "325 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/1"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69423-987-24",
          "description": "1 BLISTER PACK in 1 CARTON (69423-987-24)  / 24 TABLET in 1 BLISTER PACK",
          "marketing_start_date": "20210322",
          "marketing_end_date": "20270506",
          "sample": false
        }
      ],
      "openfda": {
        "manufacturer_name": [
          "The Procter & Gamble Manufacturing Company"
        ],
        "rxcui": [
          "1110988"
        ],
        "spl_set_id": [
          "efb69cc1-a745-6efc-e053-2a95a90abdc9"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "362O9ITL9D",
          "9D2RTI9KYH",
          "495W7451VQ",
          "04JA59TNSJ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET",
      "spl_id": "5afafeef-6087-c433-e063-6394a90a469a",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180801",
      "product_id": "69423-987_5afafeef-6087-c433-e063-6394a90a469a",
      "application_number": "M012",
      "brand_name_base": "Vicks DayQuil VapoCOOL SEVERE",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}